Export

EN
FR
Ethionamide
Essential medicine status
Section:
6. Anti-infective medicines 6.2. Antibacterials 6.2.5. Antituberculosis medicines
ATC codes: J04AD03
EMLc
Indication
Multi-drug resistant Mycobacterium tuberculosis ICD11 code: ML32.00
INN
Ethionamide
Medicine type
Chemical agent
List type
Core (EML)
(EMLc)
Formulations
Oral > Solid > dispersible tablet: 125 mg (EMLc)
Oral > Solid > tablet: 250 mg
EML status history
First added in 1982 (TRS 685)
Removed in 1987 (TRS 770)
Added in 1999 (TRS 895)
Changed in 2003 (TRS 920)
Changed in 2007 (TRS 950)
Changed in 2013 (TRS 985)
Changed in 2019 (TRS 1021)
Changed in 2021 (TRS 1035)
Changed in 2023 (TRS 1049)
Changed in 2025 (TRS 1064)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
protionamide (ATC codes: J04AD01)
Patent information
Patents have expired in most jurisdictions
Wikipedia
Ethionamide
DrugBank
Ethionamide
Summary of evidence and Expert Committee recommendations
The Expert Committee recommended the transfer of listings for medicines for multi-drug resistant tuberculosis from the complementary to the core list of the EML and EMLc.